Trials / Completed
CompletedNCT01278446
Extensively Hydrolyzed Formula: Hypoallergenicity
Evaluation of Hypoallergenicity of a 100% Whey, Extensively Hydrolyzed Infant Formula
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 2 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this clinical trial is to determine whether a new extensively hydrolyzed infant formula is hypoallergenic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Extensively hydrolyzed, whey protein infant formula | New hydrolyzed formula |
| OTHER | Extensively hydrolyzed, casein protein infant formula | Commercially available hydrolyzed infant formula |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-06-01
- Completion
- 2012-08-01
- First posted
- 2011-01-17
- Last updated
- 2013-11-04
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01278446. Inclusion in this directory is not an endorsement.